Zura Bio Ltd
ZURACIK 0001855644 · Biological Products, (No Diagnostic Substances) · Nasdaq
- JATT Acquisition Corp (until 2023-03-21)
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$75.7M
−31.0% YoY
Q1 May 2026
EPS Diluted (TTM)
−$0.79
−76.7% YoY
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$38.34M
Q1 May 2026
Cash
$225.59M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
95M sh
Q1 May 2026
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.
Balance Sheet
Cash vs Debt
Latest news
All news →-
Moderate Neutral
Zura Bio (ZURA) Amends Equity Award Plan; Board Chair Grant Added
Zura Bio has amended its equity incentive plan for the second time, adding a special one-time stock grant for its board chair.